Table 2.
Expression of cellular immunity, HsCRP and d-dimer in patients with cancer and controls
| Patients with cancer (pg/ml) | controls (pg/ml) | P value | |
|---|---|---|---|
|
|
|||
| N=144 | N=200 | ||
| CD3 | 60.71 (14.64) | 64.91 (12.29) | 0.004 |
| CD4 | 32.31 (11.30) | 37.35 (11.26) | 0.000 |
| CD8 | 25.00 (9.77) | 22.16 (7.94) | 0.005 |
| CD4CD8 | 1.30 (0.87-2.08) | 1.80 (1.40-2.50) | 0.000 |
| CD16CD56 | 11.95 (9.92-16.18) | 9.75 (5.43-15.75) | 0.035 |
| CD19 | 6.64 (3.88-12.10) | 10.20 (6.35-15.28) | 0.000 |
| D-Dimer | 0.19 (0.05-0.39) | 0.08 (0.05-0.24) | 0.000 |
| HsCRP | 11.40 (4.70-44.05) | 3.00 (0.83-14.90) | 0.000 |
CD3, CD4, CD8 were shown with mean (SD) and compared by Student’s t test. CD4/CD8, CD16CD56, CD19, D-Dimer and HsCRP were expressed as median (p25th-p75th) and compared by Mann-Whitney U test.